Pharmacogenetics to Avoid Adverse Reactions in Cardiology: Ready for Implementation?

Cardiovascular Diseases (CVs) are one of the main causes of mortality and disability around the world. Advances in drug treatment have greatly improved survival and quality of life in the past decades, but associated adverse events remain a relevant problem. Pharmacogenetics can help individualize c...

Descripción completa

Detalles Bibliográficos
Autores principales: García-González, Xandra, Salvador-Martín, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619366/
https://www.ncbi.nlm.nih.gov/pubmed/34834533
http://dx.doi.org/10.3390/jpm11111180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619366/
https://www.ncbi.nlm.nih.gov/pubmed/34834533
http://dx.doi.org/10.3390/jpm11111180

Ejemplares similares